Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Centurion Executes Option Agreement for Limestone Gold Project, near Zijin's Rosebel Gold Mine in Suriname
